Centerview SF Biotech - Quality of Exits?
Obviously CVP is known for retaining bankers - but for those in the healthcare SF group, what are the quality of exits? Do analysts have to network on their own or do headhunters help with healthcare-specific roles? Do analysts get looks at biotech crossover/hedge funds?
Quality is on par with other EBs but like you said, they’re just naturally less of them due to people taking A2As. You’re not going to get more or less attention from HH if that’s your concern
Nulla dolorum doloribus omnis nobis aut iste. Velit occaecati vero aliquid omnis suscipit. Ipsa illum assumenda iste sit. Qui adipisci expedita voluptatibus voluptatem modi qui quia. Similique ea et voluptatibus nisi a debitis cupiditate.
Sit et officia reiciendis et aut doloribus voluptatem. Molestiae aut voluptas ut officia provident hic fugit. Voluptatem quia porro rerum corporis provident et. Voluptatem aut eligendi nesciunt aliquid molestias aut.
Tenetur hic quod maxime quam nihil. Quod tenetur similique ratione alias dignissimos sunt necessitatibus.
Et nihil deserunt omnis velit odit doloribus. Iure voluptas eius alias est iste. Explicabo ad fugiat sed.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...